MAVS and viral infectious disease: Several molecules like NLRX1 and DUBs regulate RIG-I binding to MAVS at the mitochondria or directly target MAVS for degradation, thus acting as a counterbalance to prevent overproduction of Type I Interferons during a persistent viral infection.